As 2020 Closes, Many Questions Remain about Youth Substance Use Trends
NIDA-funded research aims to help understand teen drug use and its effects
Nora's Blog
NIDA-Supported Science Leads to First FDA-Approved Medication for Opioid Withdrawal
|
This week, the Food and Drug Administration (FDA) approved lofexidine, the first medication targeted specifically to treat the physical symptoms associated with opioid withdrawal.
5 Comments
Million-Participant NIH Study Could Yield Important Insights into Addiction and Pain
|
New data-gathering and analytic capabilities are enabling the kinds of massive, long-term studies needed to investigate genetic, environmental, and lifestyle factors that contribute to disease.
The True, Deadly Scope of America’s Fentanyl Problem
|
Today, a new analysis in JAMA by epidemiologists at NIDA and the Substance Abuse and Mental Health Services Administration reveals the scope of the crisis, and the rapidity with which...
Listening to Patients’ Voices in Developing New Opioid Addiction Treatments
|
One of the pillars of the current federal initiatives to end the opioid crisis is the development of new medications to treat opioid addiction. The FDA Patient-Focused Drug Development Initiative...
What Does It Mean When We Call Addiction a Brain Disorder?
|
Informed Americans no longer view addiction as a moral failing, and more and more policymakers are recognizing that punishment is an ineffective and inappropriate tool for addressing a person’s drug...
Could Naltrexone Be Used to Treat Pregnant Women with Opioid Addiction?
|
A recent study published in Lancet found that extended-release naltrexone was equally effective at reducing illicit opioid use as the partial agonist buprenorphine if patients could be successfully initiated on...
NIDA’s Past-Year Achievements Point the Way Toward Future Advances
|
2017 brought exciting new basic science findings, including some striking new insights into the structure and functioning of receptors that play important roles in substance use, addiction, and pain.
Monitoring the Future Results Show Reduced Opioid Misuse but Popularity of Vaping Among Youth
|
Today the results of the 2017 Monitoring the Future (MTF) survey were released by NIDA-funded researchers at the University of Michigan at Ann Arbor, and overall the news is encouraging.
NIDA’S Avant-Garde Award Competition Continues to Foster Transformative HIV/AIDS Research
|
NIH-funded science continues to make great strides in the fight against HIV. To foster such research, 10 years ago NIDA created its Avant-Garde Award competition to fund bold projects that...
Mobilizing Citizen Science to Address the Overdose Epidemic
|
Social media and crowdsourcing apps could be particularly useful for gathering and sharing information in real time about overdoses and using that information to prevent overdose deaths, thereby translating “citizen...
